Abbott Laboratories Headquarters
Rediff.com » News » Abbott Laboratories Headquarters
News for Abbott Laboratories Headquarters
Web results for Abbott Laboratories Headquarters
Novartis drug Afinitor significantly extended time without disease progression in women with HER2 positive advanced breast cancer
BOLERO-3 is a Phase III, randomized, double-blind study of everolimus plus trastuzumab and vinorelbine conducted at 159 clinical trial sites... ...
http://www.andhranews.net/Business/2013/Novartis-drug-Afinitor-significantly-extended-time-21847.htmGlobal Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview..
Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Gl... FARMINGTON, Conn.,... ...
http://in.advfn.com/p.php?pid=nmona&article=57584168Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
/PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the US market launch of its... ...
http://in.advfn.com/p.php?pid=nmona&article=57376623 Now, AttorneyOne Can Provide Advice for Legal Counsel
A new study published online on January 31st, 2013, in the journal of Neurology, Neurosurgery & Psychiatry revealed that prenatal exposure to... ...
http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=597477SC's Glivec ruling setback to foreign pharma firms
SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness Vidya Krishnan | C.H. Unnikrishnan... ...
http://www.livemint.com/Industry/Xo7O5oVcFxHEL98hO8oYHK/SCs-GLivec-ruling-setback-to-foreign-pharma-firms.htmlTop Coverage News
© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly